A Hypercompact CRISPR Technology Developed by GenKOre is deemed a Potential Game Changer in Gene Therapy.

/PRNewswire/ -- On September 2, 2021, a scientific paper from GenKOre on the new hypercompact CRISPR system called CRISPR/Cas12f-GE was published in an online...

Related Keywords

South Korea ,South Korean ,Yong Sam Kim ,Korea Research Institute Of Bioscience Biotechnology ,Korea Research Institute ,Nature Biotechnology ,Genkore ,